
North America Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031
Description
North America Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031
The North America Cellulite Treatment Market would witness market growth of 9.5% CAGR during the forecast period (2024-2031).
The US market dominated the North America Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $1,828.3 Million by 2031. The Canada market is experiencing a CAGR of 10% during (2024 - 2031). Additionally, The Mexico market would experience a CAGR of 10.5% during (2024 - 2031).
Cellulite, often described as the dimpled or lumpy appearance of the skin, affects a large percentage of the population, particularly women, and is commonly found on the thighs, hips, buttocks, and abdomen. Although cellulite does not pose any health risks, it can significantly impair an individual's self-esteem and body image, prompting considerable interest in exploring treatment alternatives.
According to the National Library of Medicine, very little is known about the prevalence and incidence of cellulite and the predisposing factors for cellulite development because of a lack of robust epidemiologic data. Despite this shortcoming, it is widely reported in the literature that an estimated 80% to 90% of postpubertal females are affected by this condition. There is no particular age of onset for cellulite. It can occur at any age postpuberty, although it mostly appears between the ages of 20 and 30. Males are rarely affected by cellulite. In about 2% of males, cellulite may develop due to androgen deficiency secondary to castration, hypogonadism, Klinefelter's syndrome, or estrogen or antiandrogen therapy for prostate cancer.
The increasing demand for cellulite treatment in the US can be linked to the significant growth in the older population. The US Census Bureau estimates that between 1920 and 2020, the population over 65 grew by 50.9 million, or nearly five times the overall population growth rate of approximately 1,000%. Therefore, because of these elements, the regional market will grow rapidly in the coming years.
Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- Candela Corporation (Syneron Medical)
- Bausch Health Companies, Inc.
- Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- AbbVie, Inc.
- Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- Hologic, Inc.
- Galderma S.A.
- Zimmer MedizinSysteme GmbH
- Endo International PLC
- Merz Pharma GmbH & Co. KGaA
By Gender
- Female
- Male
- Non-invasive
- Topical
- Minimally Invasive
- Soft Cellulite
- Hard Cellulite
- Edematous
- Clinics & Beauty Centers
- Hospitals
- Others
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
119 Pages
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 North America Cellulite Treatment Market, by Gender
- 1.4.2 North America Cellulite Treatment Market, by Procedure Type
- 1.4.3 North America Cellulite Treatment Market, by Cellulite Type
- 1.4.4 North America Cellulite Treatment Market, by End User
- 1.4.5 North America Cellulite Treatment Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter’s Five Forces Analysis
- Chapter 4. Recent Strategies Deployed in Cellulite Treatment Market
- Chapter 5. North America Cellulite Treatment Market by Gender
- 5.1 North America Female Market by Region
- 5.2 North America Male Market by Region
- Chapter 6. North America Cellulite Treatment Market by Procedure Type
- 6.1 North America Non-invasive Market by Country
- 6.2 North America Topical Market by Country
- 6.3 North America Minimally Invasive Market by Country
- Chapter 7. North America Cellulite Treatment Market by Cellulite Type
- 7.1 North America Soft Cellulite Market by Country
- 7.2 North America Hard Cellulite Market by Country
- 7.3 North America Edematous Market by Country
- Chapter 8. North America Cellulite Treatment Market by End User
- 8.1 North America Clinics & Beauty Centers Market by Country
- 8.2 North America Hospitals Market by Country
- 8.3 North America Others Market by Country
- Chapter 9. North America Cellulite Treatment Market by Country
- 9.1 US Cellulite Treatment Market
- 9.1.1 US Cellulite Treatment Market by Gender
- 9.1.2 US Cellulite Treatment Market by Procedure Type
- 9.1.3 US Cellulite Treatment Market by Cellulite Type
- 9.1.4 US Cellulite Treatment Market by End User
- 9.2 Canada Cellulite Treatment Market
- 9.2.1 Canada Cellulite Treatment Market by Gender
- 9.2.2 Canada Cellulite Treatment Market by Procedure Type
- 9.2.3 Canada Cellulite Treatment Market by Cellulite Type
- 9.2.4 Canada Cellulite Treatment Market by End User
- 9.3 Mexico Cellulite Treatment Market
- 9.3.1 Mexico Cellulite Treatment Market by Gender
- 9.3.2 Mexico Cellulite Treatment Market by Procedure Type
- 9.3.3 Mexico Cellulite Treatment Market by Cellulite Type
- 9.3.4 Mexico Cellulite Treatment Market by End User
- 9.4 Rest of North America Cellulite Treatment Market
- 9.4.1 Rest of North America Cellulite Treatment Market by Gender
- 9.4.2 Rest of North America Cellulite Treatment Market by Procedure Type
- 9.4.3 Rest of North America Cellulite Treatment Market by Cellulite Type
- 9.4.4 Rest of North America Cellulite Treatment Market by End User
- Chapter 10. Company Profiles
- 10.1 Candela corporation (Syneron Medical)
- 10.1.1 Company Overview
- 10.1.2 Recent strategies and developments:
- 10.1.2.1 Partnerships, Collaborations, and Agreements:
- 10.1.2.2 Product Launches and Product Expansions:
- 10.1.3 SWOT Analysis
- 10.2 Bausch Health Companies, Inc
- 10.2.1 Company Overview
- 10.2.2 Financial Analysis
- 10.2.3 Segmental and Regional Analysis
- 10.2.4 Research & Development Expense
- 10.2.5 Recent strategies and developments:
- 10.2.5.1 Trials and Approvals:
- 10.2.6 SWOT Analysis
- 10.3 Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
- 10.3.1 Company Overview
- 10.3.2 Recent strategies and developments:
- 10.3.2.1 Partnerships, Collaborations, and Agreements:
- 10.3.2.2 Product Launches and Product Expansions:
- 10.3.3 SWOT Analysis
- 10.4 AbbVie, Inc.
- 10.4.1 Company Overview
- 10.4.2 Financial Analysis
- 10.4.3 Regional Analysis
- 10.4.4 Research & Development Expense
- 10.4.5 Recent strategies and developments:
- 10.4.5.1 Product Launches and Product Expansions:
- 10.4.5.2 Acquisition and Mergers:
- 10.4.6 SWOT Analysis
- 10.5 Hologic, Inc.
- 10.5.1 Company Overview
- 10.5.2 Financial Analysis
- 10.5.3 Segmental and Regional Analysis
- 10.5.4 Research & Development Expenses
- 10.5.5 SWOT Analysis
- 10.6 Galderma S.A.
- 10.6.1 Company Overview
- 10.6.2 SWOT Analysis
- 10.7 Endo International PLC
- 10.7.1 Company Overview
- 10.7.2 Financial Analysis
- 10.7.3 Segmental Analysis
- 10.7.4 Research & Development Expense
- 10.7.5 Recent strategies and developments:
- 10.7.5.1 Trials and Approvals:
- 10.7.5.2 Acquisition and Mergers:
- 10.7.6 SWOT Analysis
- 10.8 Merz Pharma GmbH & Co. KGaA
- 10.8.1 Company Overview
- 10.8.2 SWOT Analysis
- 10.9 Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
- 10.9.1 Company Overview
- 10.9.2 SWOT Analysis
- 10.10. Zimmer MedizinSysteme GmbH
- 10.10.1 Company Overview
- 10.10.2 SWOT Analysis
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.